NCT04436458View on ClinicalTrials.gov

Niclosamide In Moderate COVID-19

PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

January 20, 2022

Primary Completion Date

January 20, 2022

Study Completion Date

January 20, 2022

Conditions
COVID
Interventions
DRUG

Niclosamide Oral Tablet

Continued SOC therapy together with niclosamide TID for 14 days

DRUG

Placebo

Continued SOC therapy together with placebo tablets matching niclosamide for 14 days

Sponsors
All Listed Sponsors
lead

Entero Therapeutics

INDUSTRY